Endocrinology, Vol 123, 1225-1229, Copyright © 1988 by Endocrine Society

ARTICLES

Dietary phosphorus and 1,25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I

BP Halloran and EM Spencer
Veterans Administration Medical Center, San Francisco, California 94121.

Hypophysectomy abolishes the increase in serum 1,25-dihydroxyvitamin D [1,25-(OH)2D] induced by restriction of dietary phosphorus. Administration of GH increases circulating insulin-like growth factor I levels (IGF-I) and restores, in part, the responsiveness of serum 1,25- (OH)2D to restriction of dietary phosphorus. To determine whether the GH-dependent increase in serum 1,25-(OH)2D induced by restriction of dietary phosphorus is mediated by IGF-I, we measured the serum concentration of 1,25-(OH)2D in hypophysectomized rats treated with either GH (100 micrograms/day) or recombinant human IGF-I (150 micrograms/day) and fed either a normal or low phosphorus diet for 6 days. Restriction of dietary phosphorus in sham-hypophysectomized rats increased serum 1,25-(OH)2D from 97 +/- 13 to 251 +/- 36 pg/ml, or 159%, but had no effect on serum 1,25-(OH)2D in hypophysectomized rats. Restriction of dietary phosphorus in rats receiving GH increased, (P less than 0.001) serum 1,25-(OH)2D from 52 +/- 8 to 133 +/- 18 pg/ml, or 156%. Restriction of dietary phosphorus in rats receiving IGF-I increased (P less than 0.001) serum 1,25-(OH)2D from 33 +/- 5 to 94 +/- 11 pg/ml, or 185%, an increase equivalent to that observed in animals receiving GH. For a given diet, no significant differences were seen between the serum concentrations of 1,25-(OH)2D in animals receiving GH or IGF-I. These data indicate that IGF-I can restore the increase in serum 1,25-(OH)2D induced by restriction of dietary phosphorus to the same degree as GH. This strongly suggests that the GH-dependent increase in serum 1,25-(OH)2D induced by restriction of dietary phosphorus is mediated by IGF-I.

This article has been cited by other articles:

				M. Y. H. Zhang, X. Wang, J. T. Wang, N. A. Compagnone, S. H. Mellon, J. L. Olson, H. S. Tenenhouse, W. L. Miller, and A. A. Portale Dietary Phosphorus Transcriptionally Regulates 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Gene Expression in the Proximal Renal Tubule Endocrinology, February 1, 2002; 143(2): 587 - 595. [Abstract] [Full Text] [PDF]

				T. Yoshida, N. Yoshida, T. Monkawa, M. Hayashi, and T. Saruta Dietary Phosphorus Deprivation Induces 25-Hydroxyvitamin D3 1{{alpha}}-Hydroxylase Gene Expression Endocrinology, May 1, 2001; 142(5): 1720 - 1726. [Abstract] [Full Text]

				A. Halhali, A. R. Tovar, N. Torres, H. Bourges, M. Garabedian, and F. Larrea Preeclampsia Is Associated with Low Circulating Levels of Insulin-Like Growth Factor I and 1,25-Dihydroxyvitamin D in Maternal and Umbilical Cord Compartments J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1828 - 1833. [Abstract] [Full Text]

				A. Halhali, L. Diaz, I. Sanchez, M. Garabedian, H. Bourges, and F. Larrea Effects of IGF-I on 1,25-dihydroxyvitamin D3 synthesis by human placenta in culture Mol. Hum. Reprod., August 1, 1999; 5(8): 771 - 776. [Abstract] [Full Text] [PDF]

				M. G. Seikaly, R. Brown, and M. Baum The Effect of Recombinant Human Growth Hormone in Children With X-Linked Hypophosphatemia Pediatrics, November 1, 1997; 100(5): 879 - 884. [Abstract] [Full Text] [PDF]

				C. Menaa, F.ço. Vrtovsnik, Gér. Friedlander, M. Corvol, and M.èl. Garabédian Insulin-like Growth Factor I, a Unique Calcium-dependent Stimulator of 1,25-Dihydroxyvitamin D(3) Production J. Biol. Chem., October 27, 1995; 270(43): 25461 - 25467. [Abstract] [Full Text] [PDF]